Listen
Two doses of psilocybin over a period of eight weeks significantly reduced alcohol use and cravings for alcoholics. That’s according...
Hey guys! I promised ya'll that I will keep you updated on Compass Pathways (NASDAQ: CMPS) earnings call. There has...
In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing...
Hey guys! Today's episode is more of a fast rant on the recent press release about MindMed raising ANOTHER $19.5M...
In today's episode of "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED / MMEDF/MMQ), Compass Pathways...
We debut our first ever "Ask a Psychotherapist" segment where we take questions submitted by our listeners and have Kelli...
Hawaii may soon be more than just Paradise. It may also be a psychedelic therapy hub. A new state measure...
Hello psychedelic investors! Today’s episode will be a little different. We will discuss the recent media coverage of psychedelic stocks...
Hello Psychedelic Investors! In this new segment entitled "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED...
In this episode of the Psychedelic Spotlight Podcast, our Director of Content catches up with Christi Myers, founder and director...